Vaccination of pneumococcal infection in patients with systemic lupus erythe matosus and antiphospholipid syndrome: experience of 6 years of use

Infections remain one of the main causes of morbidity and mortality in patients with immuno-inflammatory rheumatic diseases. Objective – to study the efficacy, immunogenicity and safety of the 23-valent polysaccharide pneumococcal vaccine (PPV-23) in patients with systemic lupus erythematosus (SLE)...

Full description

Saved in:
Bibliographic Details
Main Authors: G. M. Tarasova, B. S. Belov, T. M. Reshetnyak, M. V. Cherkasova
Format: Article
Language:Russian
Published: IMA PRESS LLC 2023-06-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/3360
Tags: Add Tag
No Tags, Be the first to tag this record!